UniProt ID | BRF2_HUMAN | |
---|---|---|
UniProt AC | Q9HAW0 | |
Protein Name | Transcription factor IIIB 50 kDa subunit | |
Gene Name | BRF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 419 | |
Subcellular Localization | Nucleus . | |
Protein Description | General activator of RNA polymerase III transcription. Factor exclusively required for RNA polymerase III transcription of genes with promoter elements upstream of the initiation sites. [PubMed: 11040218] | |
Protein Sequence | MPGRGRCPDCGSTELVEDSHYSQSQLVCSDCGCVVTEGVLTTTFSDEGNLREVTYSRSTGENEQVSRSQQRGLRRVRDLCRVLQLPPTFEDTAVAYYQQAYRHSGIRAARLQKKEVLVGCCVLITCRQHNWPLTMGAICTLLYADLDVFSSTYMQIVKLLGLDVPSLCLAELVKTYCSSFKLFQASPSVPAKYVEDKEKMLSRTMQLVELANETWLVTGRHPLPVITAATFLAWQSLQPADRLSCSLARFCKLANVDLPYPASSRLQELLAVLLRMAEQLAWLRVLRLDKRSVVKHIGDLLQHRQSLVRSAFRDGTAEVETREKEPPGWGQGQGEGEVGNNSLGLPQGKRPASPALLLPPCMLKSPKRICPVPPVSTVTGDENISDSEIEQYLRTPQEVRDFQRAQAARQAATSVPNPP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
140 | Phosphorylation | LTMGAICTLLYADLD CHHHHHHHHHHHCHH | 17.43 | - | |
150 | Phosphorylation | YADLDVFSSTYMQIV HHCHHHHCHHHHHHH | 22.94 | - | |
176 | Phosphorylation | LAELVKTYCSSFKLF HHHHHHHHHHHCCCC | 5.66 | 30631047 | |
178 | Phosphorylation | ELVKTYCSSFKLFQA HHHHHHHHHCCCCCC | 28.53 | 30631047 | |
179 | Phosphorylation | LVKTYCSSFKLFQAS HHHHHHHHCCCCCCC | 23.88 | 30631047 | |
186 | Phosphorylation | SFKLFQASPSVPAKY HCCCCCCCCCCCHHH | 13.61 | 25627689 | |
188 | Phosphorylation | KLFQASPSVPAKYVE CCCCCCCCCCHHHHC | 37.93 | 25627689 | |
188 | O-linked_Glycosylation | KLFQASPSVPAKYVE CCCCCCCCCCHHHHC | 37.93 | 30379171 | |
192 | Ubiquitination | ASPSVPAKYVEDKEK CCCCCCHHHHCCHHH | 43.70 | 21906983 | |
193 | Phosphorylation | SPSVPAKYVEDKEKM CCCCCHHHHCCHHHH | 15.92 | - | |
197 | Ubiquitination | PAKYVEDKEKMLSRT CHHHHCCHHHHHHHH | 45.81 | 22817900 | |
199 | Ubiquitination | KYVEDKEKMLSRTMQ HHHCCHHHHHHHHHH | 51.38 | - | |
202 | Phosphorylation | EDKEKMLSRTMQLVE CCHHHHHHHHHHHHH | 23.39 | 24719451 | |
218 | Phosphorylation | ANETWLVTGRHPLPV HHCCEEECCCCCCCH | 26.74 | 24719451 | |
260 | Phosphorylation | LANVDLPYPASSRLQ HCCCCCCCCCHHHHH | 20.80 | 22817900 | |
295 | Ubiquitination | LDKRSVVKHIGDLLQ CCHHHHHHHHHHHHH | 27.61 | 29967540 | |
306 | Phosphorylation | DLLQHRQSLVRSAFR HHHHHHHHHHHHHHH | 28.87 | 24719451 | |
324 | Ubiquitination | AEVETREKEPPGWGQ CEEEEECCCCCCCCC | 72.70 | 21906983 | |
353 | Phosphorylation | PQGKRPASPALLLPP CCCCCCCCCHHHCCC | 17.25 | 29255136 | |
361 | Sulfation | PALLLPPCMLKSPKR CHHHCCCCCCCCCCC | 4.75 | 26638071 | |
361 | Oxidation | PALLLPPCMLKSPKR CHHHCCCCCCCCCCC | 4.75 | 26638071 | |
361 | Cysteine sulfenic acid (-SOH) | PALLLPPCMLKSPKR CHHHCCCCCCCCCCC | 4.75 | - | |
365 | Phosphorylation | LPPCMLKSPKRICPV CCCCCCCCCCCCCCC | 31.52 | 28464451 | |
376 | Phosphorylation | ICPVPPVSTVTGDEN CCCCCCCCCCCCCCC | 23.96 | 30108239 | |
377 | Phosphorylation | CPVPPVSTVTGDENI CCCCCCCCCCCCCCC | 23.48 | 28464451 | |
379 | Phosphorylation | VPPVSTVTGDENISD CCCCCCCCCCCCCCH | 38.72 | 30108239 | |
385 | Phosphorylation | VTGDENISDSEIEQY CCCCCCCCHHHHHHH | 46.82 | 30278072 | |
387 | Phosphorylation | GDENISDSEIEQYLR CCCCCCHHHHHHHHC | 33.41 | 30278072 | |
392 | Phosphorylation | SDSEIEQYLRTPQEV CHHHHHHHHCCHHHH | 5.83 | 25850435 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BRF2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BRF2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...